FDA reviews first-ever OTC birth control application

from POLITICO's Pulse Check · host POLITICO

The Food and Drug Administration is reviewing a first-of-its-kind application from HRA Pharma for Opill. If green-lit by the agency, Opill would become the first daily, hormonal birth control pill sold without a prescription. The submission of the application follows more than six years of studies the company has run. Alice Miranda Ollstein reports. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Jul 14, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

FDA reviews first-ever OTC birth control application

0:00 9:38

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of POLITICO's Pulse Check?

This episode is 9 minutes long.

When was this POLITICO's Pulse Check episode published?

This episode was published on July 14, 2022.

Can I download this POLITICO's Pulse Check episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!